Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46019

1.

Understanding the prospective of nano-formulations towards the treatment of psoriasis.

Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, Ajazuddin.

Biomed Pharmacother. 2018 Aug 10;107:447-463. doi: 10.1016/j.biopha.2018.07.156. [Epub ahead of print] Review.

PMID:
30103117
2.

Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children.

Kouwenhoven TA, Bronckers IMGJ, van de Kerkhof PCM, Kamsteeg M, Seyger MMB.

J Eur Acad Dermatol Venereol. 2018 Aug 13. doi: 10.1111/jdv.15213. [Epub ahead of print]

PMID:
30102795
3.

A cross- sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity.

Bronckers IMGJ, van Geel MJ, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB.

J Dermatolog Treat. 2018 Aug 13:1-24. doi: 10.1080/09546634.2018.1506077. [Epub ahead of print]

PMID:
30102075
4.

A Mixture of Five Bacterial Strains Attenuates Skin Inflammation in Mice.

Holowacz S, Guinobert I, Guilbot A, Hidalgo S, Bisson JF.

Antiinflamm Antiallergy Agents Med Chem. 2018 Aug 13. doi: 10.2174/1871523017666180813123823. [Epub ahead of print]

PMID:
30101719
5.

Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies.

Watson N, Wu K, Farr P, Reynolds N, Hampton P.

Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17086. [Epub ahead of print]

PMID:
30101563
6.

The frequency of specific contact allergies is reduced in psoriasis patients.

Claßen A, Buhl T, Schubert S, Worm M, Bauer A, Geier J, Molin S; IVDK study group.

Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17080. [Epub ahead of print]

PMID:
30101482
7.

Restoration of CD3+CD56+ cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells.

Dai H, Zhou Y, Tong C, Guo Y, Shi F, Wang Y, Shen P.

Cytotherapy. 2018 Aug 9. pii: S1465-3249(18)30558-9. doi: 10.1016/j.jcyt.2018.07.003. [Epub ahead of print]

PMID:
30100374
8.

Evaluation of capillary pathologies by nailfold capillaroscopy in patients with psoriasis vulgaris: study protocol for a prospective, controlled exploratory study.

Fink C, Kilian S, Bertlich I, Hoxha E, Bardehle F, Enk A, Haenssle HA.

BMJ Open. 2018 Aug 10;8(8):e021595. doi: 10.1136/bmjopen-2018-021595.

9.

Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.

Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K; BADBIR Study Group.

Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.

PMID:
30098665
10.

Role of Galectin-3 in subclinical myocardial impairment in psoriasis.

Kotwica T, Relewicz J, Rojek A, Tupikowska-Marzec M, Kabaj M, Karolko B, Maj J, Bednarek-Tupikowska G, Kosmala W, Szepietowski JC, Przewlocka-Kosmala M.

J Eur Acad Dermatol Venereol. 2018 Aug 11. doi: 10.1111/jdv.15211. [Epub ahead of print]

PMID:
30098067
11.

Use of topical antipsoriatic drugs in Denmark: A nationwide drug utilization study.

Svendsen MT, Ernst MT, Andersen KE, Andersen F, Johannessen H, Pottegård A.

Br J Dermatol. 2018 Aug 11. doi: 10.1111/bjd.17074. [Epub ahead of print]

PMID:
30098007
12.

Risankizumab for psoriasis.

Cline A, Feldman SR.

Lancet. 2018 Aug 7. pii: S0140-6736(18)31781-1. doi: 10.1016/S0140-6736(18)31781-1. [Epub ahead of print] No abstract available.

PMID:
30097360
13.

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.

Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y, Papp KA, Sofen H, Puig L, Foley P, Ohtsuki M, Flack M, Geng Z, Gu Y, Valdes JM, Thompson EHZ, Bachelez H.

Lancet. 2018 Aug 7. pii: S0140-6736(18)31713-6. doi: 10.1016/S0140-6736(18)31713-6. [Epub ahead of print]

PMID:
30097359
14.

COMMENTS ON "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".

Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.

J Am Acad Dermatol. 2018 Aug 7. pii: S0190-9622(18)32359-4. doi: 10.1016/j.jaad.2018.07.052. [Epub ahead of print] No abstract available.

PMID:
30096421
15.

Family history of immune conditions and autism spectrum and developmental disorders: Findings from the study to explore early development.

Croen LA, Qian Y, Ashwood P, Daniels JL, Fallin D, Schendel D, Schieve LA, Singer AB, Zerbo O.

Autism Res. 2018 Aug 10. doi: 10.1002/aur.1979. [Epub ahead of print]

PMID:
30095240
16.

Quantitative Analysis of the Global Proteome in Peripheral Blood Mononuclear Cells from Patients with New-Onset Psoriasis.

Wang H, Li F, Wang Y, Li Y, Yang H.

Proteomics. 2018 Aug 9:e1800003. doi: 10.1002/pmic.201800003. [Epub ahead of print]

PMID:
30094923
17.

The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Espinoza LR.

Curr Rheumatol Rep. 2018 Aug 9;20(10):58. doi: 10.1007/s11926-018-0771-z. Review.

PMID:
30094476
18.

Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis.

Chandra A, Senapati S, Roy S, Chatterjee G, Chatterjee R.

Clin Epigenetics. 2018 Aug 9;10(1):108. doi: 10.1186/s13148-018-0541-9.

19.

Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study.

Pezzolo E, Mutlu U, Vernooij MW, Dowlatshahi EA, Gisondi P, Girolomoni G, Nijsten T, Ikram MA, Wakkee M.

J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32348-X. doi: 10.1016/j.jaad.2018.07.046. [Epub ahead of print]

PMID:
30092331
20.

Serum concentrations of interleukin 18 and 25-hydroxyvitamin D3 correlate with depression severity in men with psoriasis.

Pietrzak D, Pietrzak A, Grywalska E, Kiciński P, Roliński J, Donica H, Franciszkiewicz-Pietrzak K, Borzęcki A, Socha M, Niedziałek J, Krasowska D.

PLoS One. 2018 Aug 9;13(8):e0201589. doi: 10.1371/journal.pone.0201589. eCollection 2018.

Supplemental Content

Loading ...
Support Center